Patent · US Expired

5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes

US5416209A · kind A · utility

1Cited by

2References

3Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Hanno Wild · Wuppertal, DE
Wolfgang Roeben · Bensberg, DE
Gerd Aichinger
Arnold Paessens · Haan, DE
Jorg Peters n-von Gehr · Bochum, DE

Key dates

Filing date	Nov 18, 1992
Grant date	May 16, 1995
Priority date	—
Expiry date	Nov 18, 2012

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D223/20
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes, to processes for their preparation and to their use as inhibitors of reverse transcriptase and in particular as antiretroviral agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.